Compare · QSI vs TXG

QSI vs TXG

Side-by-side comparison of Quantum-Si Incorporated (QSI) and 10x Genomics Inc. (TXG): market cap, price performance, sector, and recent activity on the wire.

Summary

  • QSI operates in Industrials, while TXG operates in Health Care - the two are in different parts of the market.
  • TXG is the larger of the two at $7.41B, about 33.4x QSI ($221.9M).
  • TXG has been more active in the news (11 items in the past 4 weeks vs 6 for QSI).
  • TXG has more recent analyst coverage (25 ratings vs 4 for QSI).
MetricQSITXG
Company
Quantum-Si Incorporated
10x Genomics Inc.
Price
-
-
Market cap
$221.9M
$7.41B
1M return
-
-19.84%
1Y return
-
+267.92%
Industry
Industrial Machinery/Components
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ
NASDAQ
IPO
2020
2019
News (4w)
6
11
Recent ratings
4
25
QSI

Quantum-Si Incorporated

Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. The company's technology has the applications in proteomics, single cell, transcriptomics, genomics, metabolomics, and drug testing and screening fields. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4Catalyzer Corporation.

TXG

10x Genomics Inc.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Latest QSI

Latest TXG